| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 07/13/2004 | US6762048 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
| 07/13/2004 | US6761789 Method of manufacturing a soft hearing aid |
| 07/13/2004 | CA2064117C 4"-and 4'-alkylthio-avermectin derivatives |
| 07/08/2004 | WO2004057316A1 Method of detecting adenosine triphosphate (atp) |
| 07/08/2004 | WO2004057011A1 Antibiotics caprazamycins d, g, d1 and g1 and process for producing the same |
| 07/08/2004 | WO2004057010A2 Deoxyribonucleotides manufacturing by enzymatic reduction of ribonucleotides |
| 07/08/2004 | US20040132686 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses |
| 07/08/2004 | US20040132684 Modified oligonucleotides or polynucleotides, with modified pyrimidine base, modified purine base, modified ribose, phosphonate linkages, or phosphorothioate linkages; viral infections, cancer, microbial infection; sustained release |
| 07/08/2004 | US20040132067 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| 07/08/2004 | DE10258008A1 Neue heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and their use |
| 07/07/2004 | EP1434782A2 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 07/07/2004 | CN1511043A Pregabalin lactose conjugates |
| 07/07/2004 | CN1510039A Anti-CD 20 embedded antibody mutant gene and its use |
| 07/06/2004 | US6759392 Inhibiting angiogenesis; using such as 2'-nh2- modified sequence 101-165 |
| 07/06/2004 | CA2071510C 2' modified oligonucleotides |
| 07/01/2004 | WO2004055199A2 A biological sample storage device and method for biological sample contamination testing |
| 07/01/2004 | WO2004055198A2 Device and method for in-line blood testing using biochips |
| 07/01/2004 | WO2004055037A2 Process for purifying oligonucleotide synthons |
| 07/01/2004 | WO2004055034A1 Polymorph |
| 07/01/2004 | WO2004055033A1 Adenosine derivative in polymorph iv form |
| 07/01/2004 | WO2004055032A1 Adenosine derivative in polymorph v form |
| 07/01/2004 | WO2004055017A1 2-nitropurine compound and process for producing the same |
| 07/01/2004 | WO2004048397A3 Detectable labeled nucleoside analogs and methods of use thereof |
| 07/01/2004 | WO2004041834A3 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
| 07/01/2004 | WO2003080649A3 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| 07/01/2004 | WO2003077215A3 Fluorescent nitrogenous base and nucleosides incorporating same |
| 07/01/2004 | US20040127735 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral |
| 07/01/2004 | US20040127454 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/01/2004 | US20040127452 C2,5'-disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 07/01/2004 | US20040127446 Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication |
| 07/01/2004 | US20040127436 1,3,5-Triazines for treatment of viral diseases |
| 07/01/2004 | US20040127435 Uses for inhibitors of inosine monophosphate dehydrogenase |
| 07/01/2004 | US20040127434 inhibitors of lipolysis, as cardioprotective agents or they may be of value in the therapy of diabetes |
| 07/01/2004 | US20040126752 High RNA binding affinity to complementary nucleic acids and are base and acid stable; treatment of cancer, viral infections |
| 07/01/2004 | DE10260592A1 New 2-(1-((hetero)aryl(oxy))-ethyl)-nitrobenzene derivatives, useful for introducing intramolecular triplet sensitized photolabile protecting groups into synthons for light-controlled biopolymer production |
| 07/01/2004 | DE10260591A1 Stepwise synthesis of biopolymer, e.g. nucleic acid, using synthons having two-stage protecting group activated by cleavage of triplet-sensitized and/or labeled photoactivatable group to allow quality control |
| 06/30/2004 | EP1432721A1 Process for the preparation of rebeccamycin and analogs thereof |
| 06/30/2004 | EP1390545A4 Biological sample processing methods and compositions that include surfactants |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | CN1509335A Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 06/30/2004 | CN1508140A Method for preparing purine derivative disodium nucleotate crystal and dealcoholing method |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/29/2004 | US6756496 Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues |
| 06/29/2004 | US6756492 Used for sequencing nucleic acids efficiently; photolabile group contains 2-nitrophenyl moiety |
| 06/24/2004 | WO2004052908A1 Process for producing phosphoroamidite |
| 06/24/2004 | WO2004052907A1 Nucleic acid labeling compounds |
| 06/24/2004 | WO2004052906A1 Anhydrous crystalline azido cytosine hemisulfate derivative |
| 06/24/2004 | WO2004052905A2 Antiviral nucleoside derivatives |
| 06/24/2004 | WO2004052903A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052899A2 Process for the production of 2'-branched nucleosides |
| 06/24/2004 | WO2004011478A3 Anti-viral 7-deaza d-nucleosides and uses thereof |
| 06/24/2004 | WO2002092766A3 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences |
| 06/24/2004 | US20040122223 Non-natural nucleotides and dinucleotides |
| 06/24/2004 | US20040121980 For therapy of Hepatitis C Virus (HCV) mediated diseases |
| 06/24/2004 | US20040121979 Pharmaceutically active uridine esters |
| 06/24/2004 | US20040121978 Adenosine A3 receptor agonists |
| 06/24/2004 | US20040121969 Antiviral nucleoside derivatives |
| 06/24/2004 | US20040118770 Multiple layer membrane and method for fabrication thereof |
| 06/24/2004 | CA2508656A1 Antiviral nucleoside derivatives |
| 06/24/2004 | CA2507573A1 Nucleic acid labeling compounds |
| 06/23/2004 | EP1431303A2 Composition for linear isothermal amplification of polynucleotide sequences |
| 06/23/2004 | EP1180112A4 Detection using degradation of a tagged sequence |
| 06/23/2004 | CN1154488C Immuno inhibitort |
| 06/22/2004 | US6753423 For preferentially modulated gene expression in liver and associated tissues |
| 06/22/2004 | US6753322 2-aminocarbonyl-9H-purine derivatives |
| 06/22/2004 | US6753309 Nucleosides for imaging and treatment applications |
| 06/22/2004 | CA2093502C Hydrazoadenosines |
| 06/17/2004 | WO2004050678A2 Compounds resistant to metabolic deactivation and methods of use |
| 06/17/2004 | WO2004050676A1 Method of fluorination |
| 06/17/2004 | WO2004018497A3 Modified nucleotides for polynucleotide sequencing |
| 06/17/2004 | US20040116688 Preparation and isolation of indolocarbazole glycosides |
| 06/17/2004 | US20040116687 oligonucleotides having reduced internucleotide charge and enhanced nuclease resistance |
| 06/17/2004 | US20040116685 Method for solution phase synthesis of oligonucleotides |
| 06/17/2004 | US20040116680 Photolabile protective groups for the synthesis of biopolymers |
| 06/17/2004 | US20040116376 useful in the treatment of neurological, cardiac, and other cellular proliferative disorders |
| 06/17/2004 | US20040116374 C2, 8-disubstituted adenosine derivatives and their different uses |
| 06/17/2004 | US20040116362 Novel nucleosides and related processes, pharmaceutical compositions and methods |
| 06/17/2004 | US20040116334 Useful as anti-bacterial agents |
| 06/17/2004 | US20040115665 Method for base sequencing and biologically active nucleic acids |
| 06/17/2004 | US20040115644 Identifying restriction fragment length polymorphisms via isothermal complexity reduction and nucleotide sequence amplification: genotyping and resequencing |
| 06/17/2004 | US20040115283 Administering parenterally a therapeutically effective amount of one or more arsenic compounds |
| 06/17/2004 | CA2508479A1 Compounds resistant to metabolic deactivation and methods of use |
| 06/16/2004 | EP1427852A2 Single nucleotide amplification and detection by polymerase |
| 06/16/2004 | EP1427743A2 Process for the synthesis of pyrazolopyrimidines |
| 06/16/2004 | EP1427738A1 Preparation of triphosphosrylated organic compounds optionally marked with phosphorus 32 or phosphorus 33 |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | CN1505636A Pharmaceutically active uridine esters |
| 06/16/2004 | CN1505635A Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides |
| 06/16/2004 | CN1153768C Process for extracting medicinal component from pueraria root |
| 06/15/2004 | US6750340 Bisphosphonate conjugates and methods of making and using the same |
| 06/15/2004 | US6750335 Nucleoside for use in the generation of preferential oligonuceotides |
| 06/15/2004 | US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 06/10/2004 | WO2004049274A2 2’-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
| 06/10/2004 | WO2004048397A2 Detectable labeled nucleoside analogs and methods of use thereof |
| 06/10/2004 | WO2004028462A3 Method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | US20040110772 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/10/2004 | US20040110720 compounds suitable as labelable precursors for synthesis of 3'-[18F]fluoro-3'-deoxythymidine ; useful in nuclear medicine, positron emission tomography (PET) to examine metabolic processes in the brain/other organs, especially in tumor diagnosis |
| 06/10/2004 | US20040110718 Anti-HCV nucleoside derivatives |
| 06/10/2004 | US20040110717 Administering as hepatitis C viricide and inhibiting replication |